These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38028219)

  • 1. Formulation of Glibenclamide proniosomes for oral administration: Pharmaceutical and pharmacodynamics evaluation.
    Alshora D; Ibrahim M; Alanazi N; Alowyid M; Ali Alnakhli Z; Mohammed Alshiban N; Maodaa S; Alyami NM; Alotaibi I
    Saudi Pharm J; 2023 Dec; 31(12):101830. PubMed ID: 38028219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration.
    Nasr M
    AAPS PharmSciTech; 2010 Mar; 11(1):85-9. PubMed ID: 20058106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs.
    Song S; Tian B; Chen F; Zhang W; Pan Y; Zhang Q; Yang X; Pan W
    Drug Dev Ind Pharm; 2015 Jan; 41(1):51-62. PubMed ID: 24111828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of proniosomes containing lornoxicam.
    Madan JR; Ghuge NP; Dua K
    Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proniosomal oral tablets for controlled delivery and enhanced pharmacokinetic properties of acemetacin.
    Shehata TM; Abdallah MH; Ibrahim MM
    AAPS PharmSciTech; 2015 Apr; 16(2):375-83. PubMed ID: 25319057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ niosome forming maltodextrin proniosomes of candesartan cilexetil: In vitro and in vivo evaluations.
    Yuksel N; Bayindir ZS; Aksakal E; Ozcelikay AT
    Int J Biol Macromol; 2016 Jan; 82():453-63. PubMed ID: 26455402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of Aceclofenac Proniosomes by Using Different Carriers, Part 1: Development and Characterization.
    Sammour RMF; Taher M; Chatterjee B; Shahiwala A; Mahmood S
    Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31323799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proniosomes as a Carrier System for Transdermal Delivery of Clozapine.
    Tareen FK; Shah KU; Ahmad N; Ur Rehman A; Shah SU; Ullah N
    Drug Dev Ind Pharm; 2020 May; ():1-24. PubMed ID: 32362194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the Bioavailability and Efficacy of Coenzyme Q10 on Alzheimer's Disease Through the Arginine Based Proniosomes.
    Ergin AD; Üner B; Balcı Ş; Demirbağ Ç; Benetti C; Oltulu Ç
    J Pharm Sci; 2023 Nov; 112(11):2921-2932. PubMed ID: 37506768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proniosome: A Promising Approach for Vesicular Drug Delivery.
    Ajrin M; Anjum F
    Turk J Pharm Sci; 2022 Aug; 19(4):462-475. PubMed ID: 36047601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Different Carriers on In Vitro and In Vivo Drug Release Behavior of Aceclofenac Proniosomes.
    Sammour RMF; Chatterjee B; Taher M; Saleh MSM; Shahiwala A
    Curr Drug Deliv; 2021; 18(9):1272-1279. PubMed ID: 33605859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced oral bioavailability of isradipine via proniosomal systems.
    Veerareddy PR; Bobbala SK
    Drug Dev Ind Pharm; 2013 Jun; 39(6):909-17. PubMed ID: 22998221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
    Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
    Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Optimization of Proniosomal Formulation of Irbesartan Using a Box-Behnken Design to Enhance Oral Bioavailability: Physicochemical Characterization and
    Mujtaba MA; Kaleem M; Chaware R; Ingole A; Asiri YI; Hassan MZ; Sabale V; Sabale P; Anwer MK; Mahmood D; Aldawsari MF
    ACS Omega; 2024 Apr; 9(14):16346-16357. PubMed ID: 38617636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.
    Aboelwafa AA; El-Setouhy DA; Elmeshad AN
    AAPS PharmSciTech; 2010 Dec; 11(4):1591-602. PubMed ID: 21063815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
    Wen MM; Farid RM; Kassem AA
    J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of proniosomal glibenclamide formulation protects testicular tissue from hyperglycemia fluctuations and ROS via
    Alyami NM; Alnakhli ZA; Alshiban NM; Maodaa S; Almuhaini GA; Almeer R; Alshora D; Ibrahim M
    Heliyon; 2024 May; 10(10):e31283. PubMed ID: 38813164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Evaluation of Optimized Thiolated Chitosan Proniosomal Gel Containing Duloxetine for Intranasal Delivery.
    Khatoon M; Sohail MF; Shahnaz G; Ur Rehman F; Fakhar-Ud-Din ; Ur Rehman A; Ullah N; Amin U; Khan GM; Shah KU
    AAPS PharmSciTech; 2019 Aug; 20(7):288. PubMed ID: 31410741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol proniosomes as a convenient nanoingredient for functional food.
    Schlich M; Lai F; Pireddu R; Pini E; Ailuno G; Fadda AM; Valenti D; Sinico C
    Food Chem; 2020 Apr; 310():125950. PubMed ID: 31830712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technology overview and drug delivery application of proniosome.
    Ahmad MZ; Mohammed AA; Mokhtar Ibrahim M
    Pharm Dev Technol; 2017 May; 22(3):302-311. PubMed ID: 26794727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.